TMO · Thermo Fisher Scientific Inc
$609.82
+1.10% last session
End-of-day data · close of 2026-09-11
Market cap
$223B
Enterprise value
$263B
Trailing P/E
32.6
Forward P/E
21.9
Dividend yield
0.0%
Beta
0.85
Avg volume
2M
Employees
125K
Daily Change %
1.10%
5 Days Change
-1.32%
10 Days Change
-1.85%
30 Days Change
0.11%
60 Days Change
14.92%
Month to Day Change
0.86%
Year to Day Change
4.74%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — TMO
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-09-03
Latest call per bank · past 12 months
Morgan Stanley
Overweight$650
+7.8% vs priceRBC Capital
Sector Perform$580
-3.8% vs priceBarclays
Overweight$650
+7.8% vs priceHSBC
Hold$540
-10.5% vs priceWells Fargo
Overweight$615
+2.0% vs priceCitigroup
Buy$685
+13.6% vs priceGoldman Sachs
Buy$685
+13.6% vs priceUBS
Neutral$590
-2.2% vs priceJP Morgan
Overweight$650
+7.8% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-03 | CLSA | Initiates | Outperform | $0.00 → $748 |
| 2026-07-27 | Piper Sandler | Maintains | Neutral | $510 → $600 |
| 2026-07-27 | Morgan Stanley | Maintains | Overweight | $620 → $650 |
| 2026-07-24 | RBC Capital | Maintains | Sector Perform | $490 → $580 |
| 2026-07-24 | Barclays | Maintains | Overweight | $625 → $650 |
| 2026-07-06 | Evercore ISI Group | Maintains | Outperform | $575 → $570 |
| 2026-06-11 | Piper Sandler | Initiates | Neutral | $0.00 → $510 |
| 2026-06-03 | HSBC | Downgrade | Buy → Hold | $670 → $540 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 55 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 5.4% above the 50-day MA ($578.49).
- Price vs 200-day MA: Trading 13.8% above the 200-day MA ($536.03).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-4.43) — short-term momentum is fading.
- 52-week range: Price is within 5% of the 52-week high ($638.18).
TMO Price Chart
Loading chart for TMO…
Fundamentals
About Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
More in Diagnostics & Research
DHR
Danaher Corporation
$141B -10.1% YTD
NTRA
Natera, Inc.
$47B 44.2% YTD
IQV
IQVIA Holdings, Inc.
$42B 14.0% YTD
IDXX
IDEXX Laboratories, Inc.
$40B -23.8% YTD
A
Agilent Technologies, Inc.
$40B 7.0% YTD
WAT
Waters Corporation
$39B 6.6% YTD
ILMN
Illumina, Inc.
$30B 56.3% YTD
MTD
Mettler-Toledo International, I
$26B -7.4% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.